Synthesis of novel pyrimido[4,5‐ b ]quinolines as potential anticancer agents and HER2 inhibitors
Chemical Biology & Drug Design · 2023
DOI: 10.1111/cbdd.14307 ↗At a glance
Journal article in Chemical Biology & Drug Design, 2023. Written by Nahla Said M Ibrahim and 3 co-authors. Institution: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Major MEDLINE topics: Quinolines, Antineoplastic Agents, Erb-b2 Receptor Tyrosine Kinases. Cited 9 times so far (Crossref); 65 references. Funded by: Faculty of Pharmacy, Cairo University.
Abstract (original language)
A series of N ‐arylpyrimido[4,5‐ b ]quinolines 3a–e and 2‐aryl‐2,3‐dihydropyrimido[4,5‐ b ]quinoline‐4(1 H )‐ones 5a–e was designed and synthesized as potential anticancer agents against breast cancer. Compounds 3e , 5a, 5b , 5d, and 5e showed promising activity against the MCF‐7 cell line. Among them, compound 5b was the most active with IC 50 of 1.67 μM. Compound 5b promoted apoptosis and induced cell cycle arrest at S phase. 5b increased the level of pro‐apoptotic proteins p53, Bax, and caspase‐7 and inhibited the anti‐apoptotic protein Bcl‐2. Furthermore, all the synthesized compounds were docked into the crystal structure of HER2 (PBD: 3 pp0). Compounds 3e , 5a, 5b , 5d, and 5e showed good energy scores and binding modes. Finally, Compound 5b was evaluated on the HER2 assay and revealed good inhibition with IC 50 of 0.073 μM.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
ORCID profiles: Nahla Said M Ibrahim
Funding
- Faculty of Pharmacy, Cairo University
Cite
APA
Ibrahim, N. S. M., Kadry, H. H., Zaher, A. F., & Mohamed, K. O. (2023). Synthesis of novel pyrimido[4,5‐ b ]quinolines as potential anticancer agents and HER2 inhibitors. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14307
Vancouver
Ibrahim NSM, Kadry HH, Zaher AF, Mohamed KO. Synthesis of novel pyrimido[4,5‐ b ]quinolines as potential anticancer agents and HER2 inhibitors. Chemical Biology & Drug Design. 2023. doi:10.1111/cbdd.14307
BibTeX
@article{Ibrahim2023,
author = {Ibrahim, Nahla Said M and Kadry, Hanan H and Zaher, Ashraf F and Mohamed, Khaled O},
title = {Synthesis of novel pyrimido[4,5‐ b ]quinolines as potential anticancer agents and HER2 inhibitors},
journal = {Chemical Biology & Drug Design},
year = {2023},
doi = {10.1111/cbdd.14307}
}
EUVIMED